Yazan Meqbil
Affiliations: | 2020- | Medicinal Chemistry and Molecular Pharmacology | Purdue University, West Lafayette, IN, United States |
Google:
"Yazan Meqbil"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| French AR, Meqbil YJ, van Rijn RM. (2023) ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment. Frontiers in Pharmacology. 14: 1295518 |
| Hennessy MR, Gutridge AM, French AR, et al. (2023) Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor. Journal of Medicinal Chemistry |
| Meqbil YJ, Rijn RMV. (2022) Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors. Pharmaceuticals (Basel, Switzerland). 15 |
| Meqbil YJ, Su H, Cassell RJ, et al. (2021) Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities. Molecules (Basel, Switzerland). 26 |
| Sharma KK, Cassell RJ, Meqbil YJ, et al. (2021) Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands. Rsc Medicinal Chemistry. 12: 1958-1967 |
| Sharifi F, Meqbil YJ, Otte A, et al. (2021) Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharmaceutical Research |
| Meqbil Y, Su H, Cassell R, et al. (2021) Identification of a Novel δOR Selective Agonist Chemotype, Notably Devoid of a Basic Nitrogen The Faseb Journal. 35 |